Table 2.
Demographic and clinical features and CSF levels of sPLA2 activity of AD and age-matched controls.a
| Control | AD | Statistic value | P | |
|---|---|---|---|---|
| 19 | 33 | |||
| Male sex, n (%) | 12 (63) | 17 (52) | NA | 0.564 |
| Age, years | 62.6 (8.2) | 66.8 (3.6) | z = 212.5 | 0.055 |
| MMSE | 29.5 (0.5) | 22.7 (6.4) | z = 58.5 | 0.0008 |
| ApoE4 carrier, n (%) | 0 (0) | 19 (58) | NA | <0.0001 |
| sPLA2 activity, ΔFI/min | 3.8 (0.9) | 5.1 (1.3) | tdf=50 = 3.59 | 0.0008 |
a
Differences between groups were assessed using Fisher test. Continuous variables are expressed as mean (SD), and differences between groups were assessed using Mann–Whitney test (age, MMSE) or 2-tailed Student t-test (sPLA2 activity). NA, not applicable.